SURGICAL TREATMENT IN HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY

Vedat Erentuğ, *Nilgün Ulusoy Bozbuğa, Akın İzgi, **Atakan Erkılınç, Eylem Yayla Akvardar, Kaan Kırali, Gökhan İpek, Esat Akıncı, Cevat Yakut

Koşuyolu Kalp Eğitim ve Araştırma Hastanesi, Kalp Damar Cerrahisi Kliniği, İstanbul
*Koşuyolu Kalp Eğitim ve Araştırma Hastanesi, Kardiyoloji Kliniği, İstanbul
**Koşuyolu Kalp Eğitim ve Araştırma Hastanesi, Anestözyoloji ve Reanimasyon Kliniği, İstanbul

Background:Hypertrophic obstructive cardiomyopathy is a primary cardiac muscular disease with unkonwn etiology, characterised by small left ventricular cavity, increased systolic function and diastolic dysfunction. We presented here 10 patients with hypertrophic obtructive cardiomyıopathy, who were operated on in our clinics, with literature review.

Methods:Between 1985 and 2002, ten patients were operated on due to hypertrophic obstructive cardiomyopathy in our clinics. Eight patients aged between 5 and 68 years were female and 2 were male. Palpitation and dyspnea were the primary symptoms. All patients underwent pre- and postoperative echocardiographic examination and cardiac catheterisation was performed in 8 patients.

Results:There was no early and late postoperative mortality. In two patients temporary complete AV-blok was observed during early postoperative period. During long-term follow-up supraventricular tachycardia was observed and one patient was presented with congestive heart failure.

Conclusion: Septal myectomy is the surgical treatment of choice performed with low mortality and morbidity rates in patients with hypertrophic obtructive cardiomyopathy for whom the pharmacological treatment modalities are insufficient.

Keywords : Hypertrophic cardiomyopathy, myectomy, cardiac muscle disease, asymetric septal hypertrophy

Viewed : 33110

Downloaded : 3972